Effectiveness and Drug Survival of Apremilast in 65 Patients With Psoriasis and/or Psoriatic Arthritis

Actas Dermosifiliogr. 2022 May;113(5):532-535. doi: 10.1016/j.ad.2020.08.034. Epub 2021 Dec 17.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis, Psoriatic* / drug therapy
  • Humans
  • Psoriasis* / chemically induced
  • Psoriasis* / complications
  • Psoriasis* / drug therapy
  • Thalidomide / analogs & derivatives
  • Thalidomide / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Thalidomide
  • apremilast